Peer-influenced content. Sources you trust. No registration required. This is HCN.
Conexiant
Early trials suggest red‑light therapy may slow pediatric myopia progression, but unanswered questions around long‑term retinal safety and clinical positioning remain.
Ophthalmology April 20th 2026
Optometric Management
A nationwide recall of more than 3 million OTC eye drops due to sterility concerns highlights the importance of routine patient counseling around non‑prescription ocular products.
Retina Today
Vigabatrin can cause irreversible peripheral retinal toxicity that is often asymptomatic, underscoring the need for consistent ophthalmic monitoring in treated patients.
Ophthalmology Advisor
FDA approval of 20‑week dosing for Eylea HD offers eligible wAMD and DME patients the potential for fewer injections while maintaining long‑term visual outcomes.
Eyewire+
Alcon’s Clareon TruPlus adds an enhanced monofocal option aimed at improving intermediate vision while preserving distance quality, with real‑world outcomes yet to be defined.
Ophthalmology Management
The first fully robot‑assisted cataract surgery marks a feasibility milestone that may shape future discussions around surgical precision, ergonomics, and access—but remains early in clinical validation.
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS